Clinical trial Recruiting at 1 site Interventional Ages 16 to 25

Short therapy program for young adults with borderline personality disorder

Official title: Short Integrative And Neurocognitive Therapy For Young Adults With Borderline Personality Disorder: a Study Model of Impulsivity Management

Run by Centre Hospitalier Universitaire de Nīmes · NCT05913544 · Data updated 2026-11-12

This study is testing a new 10-week therapy program for young adults with borderline personality disorder to see if it can help reduce impulsive behaviors and improve their overall well-being.

Quick facts

Study typeInterventional
Ages16 Years to 25 Years
SexAll
Enrollment74 (estimated)
SponsorCentre Hospitalier Universitaire de Nīmes
Academic / other
Locations1 site (Nîmes)
StatusRecruiting
StartedNovember 8, 2023
Main results expectedSeptember 2026
Study endsSeptember 2026
Registry record updatedNovember 24, 2025
Trial IDNCT05913544 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are young adults aged 16 to 25 who have a diagnosis of borderline personality disorder and meet specific severity criteria.

Probably not a fit

Patients with neurological disorders, low IQ, or those currently engaged in other specific psychotherapies for BPD may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the effectiveness of the SINTYA therapy program, which consists of one group session and one individual session per week for 10 weeks, aimed at reducing impulsivity and clinical symptoms in young adults aged 16 to 25 diagnosed with borderline personality disorder (BPD). The program is designed to address the unique neurocognitive challenges faced by this population, particularly those linked to early trauma. Participants will be assessed for various symptoms including emotional regulation difficulties, self-destructive behaviors, and overall psychosocial functioning. The study aims to provide a tailored therapeutic approach that may be more effective than traditional psychotherapies.

Why it matters

Potential benefit: If successful, this therapy could significantly improve the quality of life and mental health outcomes for young adults with borderline personality disorder.

How similar studies have gone: While there is limited information on the success of similar integrative approaches, the tailored nature of this therapy for young adults with BPD represents a novel intervention.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Diagnosis of BPD according to DSM-5 criteria and BPQ-80 scale.
* High BPD severity level: ZAN-BPD (score ≥ 18/36).
* Understand, write and read French.
* Be able to understand the nature, purpose and methodology of the study and agree to cooperate during evaluations.
* Have signed the informed consent.
* For minor patients, have signed the parental consent by at least one holder of parental authority.

Exclusion Criteria:

* Refusal to participate.
* Existence of a neurological pathology or cerebral sequelae of organic origin which could affect neurocognitive performance.
* Intelligence quotient \< 70.
* Lifetime diagnosis of schizoaffective disorder or schizophrenia (MINI-7).
* Previous or current participation in specific psychotherapy for BPD.
* Subject deprived of liberty (by judicial or administrative decision) and/or protected by law.
* Inclusion in another study including psychotherapy for the duration of the study.
* Inclusion in a drug RIPH1 study or in a REC study (European regulation of clinical trials) for the entire duration of the study.
* Subject in period of exclusion from another research protocol.

Where it's running

  • CHU de Nîmes
    Nîmes, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.